Department of Medicine, University of Southern California, Los Angeles, California 90033.
J Clin Endocrinol Metab. 2014 Nov;99(11):4015-26. doi: 10.1210/jc.2014-1850. Epub 2014 Aug 28.
Elevated TSH with normal T4 frequently occurs with chronic kidney, liver, and heart diseases. Whether isolated TSH elevations represent mild thyroid gland failure has not been established.
PubMed was searched for longitudinal studies in chronic heart, liver, or kidney disease documenting persistent isolated TSH elevations or progression to overt hypothyroidism.
Four articles met inclusion criteria. In 16 end-stage renal failure patients, four had isolated TSH elevations. All normalized within 14 months. In 452 systolic heart failure patients, 20 had isolated TSH elevations, five of 20 were persistent, and none progressed to overt hypothyroidism within 6 months. In 207 untreated chronic hepatitis C patients, 12 had isolated TSH elevations and four had increased TSH with reduced free T4; all were female, and 14 had positive antithyroid antibodies. After 1 year, two of 12 developed "clinical hypothyroidism." In 72 chronic hepatitis C patients, nine females had positive antithyroid antibodies. Two antibody-negative patients had TSH 5-6 mU/L with reduced free T4. After 1 year, three of four with positive antithyroid antibodies and baseline TSH < 4 mU/L had elevated TSH with reduced free T4.
In chronically ill patients, there is inadequate evidence to determine: 1) that isolated TSH elevations usually persist or progress to overt hypothyroidism; 2) the etiology and clinical significance of isolated TSH elevations; and 3) whether levothyroxine therapy is indicated for persistent isolated TSH elevations. Thus, isolated TSH elevations in chronic renal, cardiac, or liver diseases have not been documented to indicate mild thyroid gland failure.
慢性肾脏、肝脏和心脏疾病时常会出现 TSH 升高而 T4 正常的情况。孤立性 TSH 升高是否代表轻度甲状腺功能减退尚未确定。
通过检索 PubMed 中的慢性心脏、肝脏或肾脏疾病的纵向研究,这些研究记录了持续性孤立性 TSH 升高或进展为明显甲状腺功能减退的情况。
符合纳入标准的文章有 4 篇。在 16 例终末期肾衰竭患者中,有 4 例存在孤立性 TSH 升高。所有患者在 14 个月内均恢复正常。在 452 例收缩性心力衰竭患者中,有 20 例存在孤立性 TSH 升高,其中 5 例持续存在,但在 6 个月内均未进展为明显甲状腺功能减退。在 207 例未经治疗的慢性丙型肝炎患者中,有 12 例存在孤立性 TSH 升高,4 例存在 TSH 升高伴游离 T4 降低;所有患者均为女性,其中 14 例存在抗甲状腺抗体阳性。1 年后,有 2 例发展为“临床甲状腺功能减退症”。在 72 例慢性丙型肝炎患者中,有 9 例女性存在抗甲状腺抗体阳性。2 例抗体阴性患者的 TSH 为 5-6 mU/L,游离 T4 降低。1 年后,有 4 例抗甲状腺抗体阳性且基线 TSH < 4 mU/L 的患者 TSH 升高伴游离 T4 降低。
在慢性疾病患者中,没有足够的证据来确定:1)孤立性 TSH 升高通常持续存在或进展为明显甲状腺功能减退症;2)孤立性 TSH 升高的病因和临床意义;3)是否需要对持续性孤立性 TSH 升高进行左甲状腺素治疗。因此,慢性肾脏、心脏或肝脏疾病中的孤立性 TSH 升高尚未被证明表明轻度甲状腺功能减退。